A PHARMO Study on the Utilization of Pioglitazone in Clinical Practice in The Netherlands with Regard to Diabetic Treatment Regimen and Co-morbidities

First published 21/07/2015

Last updated 01/04/2024

EU PAS number:

EUPAS10001

Study

Finalised

Documents

Study protocol

Initial protocol

PHARMO_Protocol_Pioglitazone_DUS

English (245.46 KB - PDF)View document

Study results

AD-4833-409B-RDS-2012-10-17

English (16.7 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs